Abstract:Background: Although a larger number of antiepileptic drugs became available in the last decades, epilepsy remains drug-resistant in approximately a third of patients. Ketogenic diet (KD), first proposed at the beginning of the last century, is complex and has anticonvulsant effects, yet not completely understood. Over the last decades, different types of ketogenic diets (KDs) have been developed, namely classical KD and modified Atkins diet (MAD). They offer an effective alternative for children and adults with drug-resistant epilepsies. Methods: We review several papers on KDs as an adjunctive treatment of refractory epilepsy of children and adults, discussing its efficacy and adverse events. Because of the heterogenous, uncontrolled nature of the studies, we analyzed all studies individually, without a meta-analysis. Results: KDs may be considered first choice treatment in some specific metabolic conditions, such as glucosetransporter type 1 and pyruvate dehydrogenase deficiencies, and mitochondrial complex I defects. Preliminary findings indicate that KDs may be specifically effective in some epileptic syndromes, such as West syndrome, severe myoclonic epilepsy of infancy, myoclonic-astatic epilepsy, febrile infection related epileptic syndrome, and drug-resistant idiopathic generalized epilepsies or refractory status epilepticus. Short term adverse events are usually mild in both children and adults, including gastrointestinal symptoms, hyperlipidemia, and hypercalciuria; potential long term adverse effects include nephrolitiasis, decreased bone density, and liver steatosis. Possible atherosclerotic effects remain a concern. Patients on KDs should be carefully monitored in specialized centers during initiation, maintenance and withdrawal periods, in order to minimize such adverse events, and to improve compliance. Although the majority of KD trials on children and adults with drug-resistant epilepsies are openlabel, uncontrolled studies based on small samples, an increasing number of randomized controlled trials have provided better quality evidence on its efficacy in recent years. Conclusion: There is a need for future randomized clinical trials aimed to confirm the efficacy of KDs in specific epileptic syndromes, and to provide further information about some practical unsolved problems, i.e. for how long KD treatment should be continued.

[Ketogenic Diet and its Evidence-Based Therapeutic Implementation in Endocrine Diseases]

Ketogenic diet for human diseases: the underlying mechanisms and potential for clinical implementations

Ketogenic diet: A nutritional remedy for some metabolic disorders

Therapeutic Success of the Ketogenic Diet As A Treatment Option for Epilepsy: A Meta-Analysis

The impact of ketogenic diet on some metabolic and non‐metabolic diseases: Evidence from human and animal model experiments

Ketogenic Diets in the Treatment of Epilepsy

Current Evidence, Safety, and Practical Advice

Efficacy and Safety of a Ketogenic Diet in Children and Adolescents with Refractory Epilepsy—A Review

Therapeutic potential of the ketogenic diet: A metabolic switch with implications for neurological disorders, the gut-brain axis, and cardiovascular diseases

Therapeutic Use of the Ketogenic Diet in Refractory Epilepsy: What We Know and What Still Needs to Be Learned

Low-Calorie Ketogenic Diet: Potential Application in the Treatment of Polycystic Ovary Syndrome in Adolescents

Ketogenic Diet and Multiple Health Outcomes: An Umbrella Review of Meta-Analysis

The use of ketogenic diets in children living with drug‐resistant epilepsy, glucose transporter 1 deficiency syndrome and pyruvate dehydrogenase deficiency: A scoping review

Ketogenic Diet: A New Light Shining on Old but Gold Biochemistry

Beyond weight loss: a review of the therapeutic uses of very-low-carbohydrate (ketogenic) diets

The Efficacy and Safety of Ketogenic Diets in Drug-Resistant Epilepsy in Children and Adolescents: a Systematic Review of Randomized Controlled Trials

Ketogenic Diet and Vitamin D Metabolism: A Review of Evidence

Ketogenic Diet in patients with refractory epilepsy

Epigenome Modulation Induced by Ketogenic Diets

Ketogenic Diet in the Treatment of Epilepsy

The Therapeutic Role of Ketogenic Diet in Neurological Disorders